https://www.selleckchem.com/products/ptc-209.html
BACKGROUND One of the most dynamic areas in glutamate receptor system neurobiology is currently the identification and development of positive allosteric modulators (PAMs) of glutamate ionotropic receptors. PAM-based drugs are of great interest as promising candidates for treatment of neurological diseases such as epilepsy, Alzheimer's disease, schizophrenia, etc. Understanding the molecular mechanisms underlying biological action of natural and synthetic PAMs is a key point for modifying the original chemical compounds as well as for n
Like
Comment
Share
